1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  1. Safety

Recalls, Market Withdrawals, & Safety Alerts

 

The list below provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this page. See Additional information about recalls for a more complete listing.

The Recalls, Market Withdrawals & Safety Alerts are available on FDA’s website for three years before being archived. To search archived content, visit Search FDA Archive and input the name of the product and/or company name in the Search terms box as well as the year to get the most inclusive search results. To scroll through archived Recalls, Market Withdrawals & Safety Alerts content by year, see the Recall and Safety Alerts Archive.
Email Icon for GovDeliverySign up to receive Recalls, Market Withdrawals and Safety Alerts.
* FDA Employees: Use Chrome to Subscribe until further notice.


Filter by

A Terminated Recall is a recall where the FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard. Recalls that are not indicated as being terminated are either ongoing or completed.

Date Brand Name(s) Product Description Product Type Recall Reason Description Company Name Terminated Recall Excerpt
Hospira Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units Animal & Veterinary, Animal Drugs, Drugs, Animal Drugs Device & Drug Safety – Potential Packaging Defect Hospira Inc. … Hospira … Hospira Inc. … FOR IMMEDIATE RELEASE – May 21, 2024 - NEW YORK, NY., Hospira, Inc., a Pfizer company (“Pfizer”), is voluntarily recalling …
Hospira 4.2% Sodium Bicarbonate Injection, USP, 1% Lidocaine HCl Injection, USP, and 2% Lidocaine HCl Injection, USP Drugs Potential Presence of Glass Particulates Hospira, Inc. Terminated … Hospira … Hospira, Inc. … FOR IMMEDIATE RELEASE - October 2, 2023 - NEW YORK, NY., Hospira, Inc., a Pfizer company, is voluntarily recalling the lots …
Hospira Propofol Injection Emulsion, USP Drugs Potential presence of visible particulate Hospira, Inc., a Pfizer Company Terminated … Hospira … Hospira, Inc., a Pfizer Company … FOR IMMEDIATE RELEASE -NEW YORK, NY., August 22, 2022 Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of …
Download XLSX
Back to Top